Search filters

List of works by Haya Ascher-Svanum

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia

scientific article

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

scientific article published on July 2006

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

scientific article

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia

scientific article published on 02 February 2008

Analysis of treatment effectiveness in longitudinal observational data

scientific article

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis ⬇️

scientific article published on June 18, 2012

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

scientific article

Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.

scientific article published in July 2012

Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs

scientific article published on January 2004

Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

scientific article

Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence ⬇️

scientific article published on September 7, 2010

Challenging the assumption that improvement in functional outcomes is delayed relative to improvement in symptoms in the treatment of schizophrenia

scientific article published on 15 January 2010

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics ⬇️

scientific article published on May 17, 2011

Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia

scientific article published on April 2007

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

scientific article

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

scientific article

Clinical comparability of schizophrenia patients at two public mental health systems

scientific article published in January 2003

Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia

scientific article published on 21 December 2007

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

scientific article published on 9 February 2015

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

scientific article published on 15 March 2012

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial

scientific article

Corrigendum to "Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials" [Shizophr. Res. 130 (2011) 11–19]

scholarly article published in Schizophrenia Research

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

scientific article

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

scientific article published on 07 April 2009

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy ⬇️

scientific article published on April 20, 2011

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial

scientific article published on March 2006

Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model

scientific article published on 25 January 2011

Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia ⬇️

scientific article published on November 26, 2010

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States ⬇️

scientific article published on February 21, 2012

Costs associated with attempted suicide among individuals with bipolar disorder

scientific article published on June 1, 2010

Costs of treating patients with schizophrenia who have illness-related crisis events

scientific article

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia ⬇️

scientific article published on January 11, 2011

Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuation ⬇️

scientific article published on June 17, 2011

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

scientific article

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

scientific article

Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus

scientific article

Early onset of antipsychotic action in schizophrenia: evaluating the possibility of shorter acute efficacy trials

scientific article published in June 2010

Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited

scientific article published on July 2014

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

scientific article

Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia

scientific article

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis

scientific article published on 18 December 2010

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease

scientific article

Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia ⬇️

scientific article published on January 31, 2012

Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophrenia

scientific article published on 14 December 2012

Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis

scientific article published on 30 July 2015

Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

scientific article published on 5 October 2015

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study ⬇️

scientific article published on October 14, 2011

Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome ⬇️

scientific article published on October 1, 2010

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia ⬇️

scientific article published on February 9, 2011

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1‐year naturalistic study of schizophrenia patients in Japan ⬇️

scientific article published on June 1, 2012

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

scientific article

Item response analysis of the Positive and Negative Syndrome Scale

scientific article

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

scientific article

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study ⬇️

scientific article published on December 5, 2012

Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder

scientific article published in August 2007

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials

scientific article

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

scientific article

Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

scientific article

Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response

scientific article published on 02 June 2009

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder

scientific article published on November 2007

Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example

scientific article published on 27 May 2009

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

scientific article published on 14 June 2013

One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study

scientific article published on 13 June 2012

Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods

scientific article published on 28 June 2009

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties ⬇️

scientific article published on January 1, 2012

Overestimating the prevalence of subtherapeutic dosing of atypical antipsychotics

scientific article

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

scientific article published on 20 December 2007

Predicting Psychiatric Hospital Admission Among Adults With Schizophrenia ⬇️

scientific article published on October 1, 2011

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia

scientific article published on 18 April 2008

Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs

scientific article

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan ⬇️

scientific article published on January 13, 2012

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan ⬇️

scientific article published on December 14, 2011

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration

scientific article

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study

scientific article

Predictors of switching antipsychotic medications in the treatment of schizophrenia

scientific article

Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning

scientific article published in October 2006

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians ⬇️

scientific article published on November 3, 2011

Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives ⬇️

scientific article published on October 1, 2010

Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms

scientific article published on 21 October 2011

Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools

scientific article published on October 2007

Schizophrenia Outpatient Health Outcomes study: twelve-month findings

scientific article published on 06 June 2012

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study ⬇️

scientific article published on August 26, 2011

Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia

scientific article

Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study.

scientific article published in October 2008

The 3-year clinical and functional course of schizophrenia among individuals with and without diabetes at study entry

scientific article published in January 2007

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

scientific article published on 15 November 2006

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

scientific article published on 7 January 2010

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial

scientific article

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy

scientific article published on 14 August 2013

The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting.

scientific article published on January 2004

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial ⬇️

scientific article published on December 28, 2011

The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials

scientific article

Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis ⬇️

scientific article published on May 26, 2012

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

scientific article

Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia

scientific article published in March 2008

Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials

scientific article published on 13 April 2011

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence ⬇️

scientific article published on May 9, 2011

Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone

scientific article published on 29 April 2007

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients

scientific article published on 29 July 2009

Treatment response trajectories and antipsychotic medications: Examination of up to 18months of treatment in the CATIE chronic schizophrenia trial ⬇️

scientific article published on February 7, 2012

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons ⬇️

scientific article published on May 4, 2012

Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia

scientific article

Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia ⬇️

scientific article published on July 28, 2012

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation ⬇️

scientific article published on July 13, 2012

Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic

scientific article published in November 2005

Paulina is supported by:

About Paulina

Help